I have been talking about the need to increase the funding levels for the Department of Defense (DOD) Peer Review Prostate Cancer Research Program (PCRP) for a long period. This program has proven itself to be the single most valuable government funded prostate cancer research program. The program is designed to fund research projects that [...]
A lot has been written about the need to identify better biomarkers to both assist in the initial diagnosis of prostate cancer and then to help determine which cancers are potentially dangerous from those that are actually indolent. Finding these markers is vital, I too have written about the great need for them. However, in [...]
There is a new web site that will make finding a clinical trial specific for prostate cancer even easier. Not only can you search for trials, but now you can locate the trials by location (distance from your home zip code). Go to: https://web.archive.org/web/20170512051333/http://cancertrials4prostate.org/ or look for the link in the resource section of this [...]
The May 5 issue of the Annals of Internal Medicine carried a report about some recent research looking to identify biomarkers for aggressive prostate cancer. We have been plagued with our inability to differentiate between which prostate cancers are aggressive and will kill and which are actually indolent and will not affect a man’s life. [...]
I have returned from Michigan and again have the computer access and the time to continue sharing items relevant to our struggle. Investigators at the Duke University Prostate Center have indicated that cholesterol-lowering drugs, statins, may reduce inflammation in prostate tumors, which might hinder prostate cancer growth. "Previous studies have shown that men taking statins [...]